IP Library Assignment 024024/0806
Patent Assignment
Reel/Frame 024024/0806

Merger

Recorded: 2010-03-03 Pages: 4
Assignor
Assignee
IPSEN PHARMA S.A.S.
65 QUAI GEORGES GORSE, BOULOGNE BILLANCOURT, 92100, FRANCE
Covered Property (1)
Use of Botulinum Toxin for the Preparation of a Medicament for the Treatment of Lithiasis of Salivary Gland, Gall Bladder, Kidney, or Pancreas
Patent: 7,838,009 →
Application: 11/632,222 →
Publication: US 2008/0292661
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 8, 2008
From: D'ARBIGNY, PIERRE BERNARD; CHABRIER DE LASSAUNIERE, PIERE-ETIENNE; BARCOCK, ALAN
To: IPSEN LIMITED; SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.)
Reel/Frame 020354/0727 →
Change of Name Feb 18, 2010
From: IPSEN LIMITED
To: IPSEN DEVELOPMENTS LIMITED
Reel/Frame 023958/0182 →
Assignment of Assignor's Interest May 27, 2010
From: IPSEN DEVELOPMENTS LIMITED
To: IPSEN BIOPHARM LIMITED
Reel/Frame 024452/0646 →